10 November 2022
\n \n \n \nEstablishing preclinical models of Alzheimer\u2019s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer\u2019s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.
\n \n\n \n \n19 October 2022
\n \n \n \nEarlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.
\n \n\n \n \n17 October 2022
\n \n \n \n\n \n \n14 October 2022
\n \n \n \nHealth and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. Our department will play a major role.
\n \n\n \n \n27 September 2022
\n \n \n \nScientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).
\n \n\n \n \n21 September 2022
\n \n \n \nMount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.
\n \n\n \n \n12 September 2022
\n \n \n \nDr Rezvan Farahibozorg has received one of 17 Royal Academy of Engineering Research Fellowships for 2022.
\n \n\n \n \n18 August 2022
\n \n \n \nMany congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.
\n \n\n \n \n11 August 2022
\n \n \n \nA drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.
\n \n\n \n \n8 August 2022
\n \n \n \nProfessor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.
\n \n\n \n \n24 June 2022
\n \n \n \nText by Ian Fyfe for 'Nature Reviews Neurology'
\n \n\n \n \n15 June 2022
\n \n \n \nOur researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.
\n \n\n \n \n13 June 2022
\n \n \n \nTwo recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.
\n \n\n \n \n9 June 2022
\n \n \n \nHaving multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.
\n \n\n \n \n7 June 2022
\n \n \n \nThe 14th Quinquennial Myasthenia Gravis Federation of America International Conference was recently held in Miami with 450 delegates attending in person, including over 100 from industry.
\n \n\n \n \n27 May 2022
\n \n \n \nA study published this week in Nature Neuroscience demonstrates how studying the magnetic properties of tissue may provide a unique window into brain health and disease.
\n \n\n \n \n24 May 2022
\n \n \n \nHundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.
\n \n\n \n \n16 May 2022
\n \n \n \nA new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull \u201cstructural\u201d cells, are much more complex than previously thought.
\n \n\n \n \n16 May 2022
\n \n \n \nProfessor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.
\n \n\n \n \n13 May 2022
\n \n \n \nDr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.
\n \n\n \n \n